Genzyme Optimistic About Renagel’s Future Despite Fresenius’ Deal For PhosLo
This article was originally published in The Pink Sheet Daily
Executive Summary
Genzyme CEO does not think Fresenius will inappropriately push physicians to prescribe PhosLo.